Can MDMA Therapy Reduce Our Fear Of Dying?

Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Agregado by Siulwon
82 Vistas
Help complete the first clinical trial of MDMA-assisted psychotherapy as a treatment for anxiety associated with life-threatening illness.

Sponsored by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS), this randomized, double-blind, placebo-controlled Phase 2 study, located in Marin, Calif., is gathering preliminary data about the safety and efficacy of MDMA-assisted psychotherapy for anxiety in 18 subjects diagnosed with life-threatening illness.

The study protocol was approved by the Institutional Review Board (IRB) on September 16, 2014, by the U.S. Food and Drug Administration (FDA) on November 13, 2014, and by the Research Advisory Panel of California (RAP-C) on December 15, 2014. The U.S. Drug Enforcement Administration (DEA) approved the Principal Investigator's Schedule I license on March 13, 2015. This study is now enrolling and treating subjects.

“I felt lost, like I had no purpose...[MDMA-assisted psychotherapy] gives you the ability to look inside and go through the closets of your life. It gives you access to your emotional content.” —Study participant Andy Gold (Oakland, Calif.)

"It’s not just the medicine; it’s the therapy and the relationship with the therapists. To be cared for like that was immensely healing for me." —Study participant Wendy Donner (Marin, Calif.)


Every gift makes a difference. This study is estimated to cost $627,000, and has already raised $234,000. $393,000 is still needed to complete this study.

Your tax-deductible donation will help complete this important research.


San Francisco Chronicle | Patients in MDMA Clinical Trial Find Drug Beneficial
March 19, 2016

Inverse | People Are Taking Legal MDMA to Cure Anxiety
March 1, 2016

CBS 5/KPIX San Francisco | Patients Legally Take MDMA While Receiving Therapy In Marin County
February 26, 2016

Mother Jones | This Doctor Wants to Treat Your Crippling Fear of Death With MDMA
January 8, 2016


Principal Investigator: Phil Wolfson, M.D.
Co-Therapist: Julane Andries, LMFT
Location: Marin, California, United States
Subjects: 18 subjects with anxiety associated with life-threatening illness
Protocol: Randomized, double-blind
Treatment Method: Weekly psychotherapy sessions and two experimental day-long MDMA-assisted psychotherapy sessions, scheduled two to four weeks apart.

“These visions would bubble up and come to me piece by piece. My heart really cracked open. It helped me overcome my fear-based defenses.” —Study participant John Saul (Sausalito, Calif.)


On March 7, 2016, the eighth participant of 18 was enrolled. On April 3, investigators announced that the first participant has been scanned in an additional fMRI brain imaging study of the physiological correlates of MDMA-assisted psychotherapy in subjects with anxiety associated with life-threatening illness. The brain imaging sub-study is a collaboration between the MAPS-sponsored study and Michael Silver, Ph.D., at the Helen Wills Neuroscience Institute at the University of California, Berkeley.

For information about study participation, contact Dr. Phil Wolfson at


Based in Santa Cruz, Calif., the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. Since our founding in 1986, MAPS has disbursed over $26 million to psychedelic and medical marijuana research and education. Every dollar has come from visionary donors committed to our mission.

“We're moving toward the prescription availability of psychedelic psychotherapy with all the tools in the toolbox.” —MAPS Founder Rick Doblin, Ph.D.


Help us caption & translate this video!
Otras Drogas Other languages MDMA Maps Social

Deja tu comentario

Inicia Sesión o Registrate para dejar comentarios.


Anímate! Se el primero en comentar este video